 |
PDBsum entry 5fdc
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The anticonvulsant sulfamide jnj-26990990 and its s,S-Dioxide analog strongly inhibit carbonic anhydrases: solution and x-Ray crystallographic studies.
|
 |
|
Authors
|
 |
A.Di fiore,
G.De simone,
V.Alterio,
V.Riccio,
J.Y.Winum,
F.Carta,
C.T.Supuran.
|
 |
|
Ref.
|
 |
Org Biomol Chem, 2016,
14,
4853-4858.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
JNJ-26990990 ((benzo[b]thien-3-yl)methyl)sulfamide, a sulfamide derivative
structurally related to the antiepileptic drug zonisamide, was reported to be
devoid of carbonic anhydrase (CA, EC 4.2.1.1) inhibitory properties. Here we
report that JNJ-26990990 and its S,S-dioxide analog significantly inhibit six
human (h) isoforms, hCA I, II, VII, IX, XII and XIV, involved in crucial
physiological processes. Inhibition and X-ray crystallographic data for the
binding of the two compounds to these enzymes show significant similarity with
the zonisamide inhibitory pattern. These findings prompted us to reconsider the
structural/pharmacological requirements for designing effective antiepileptics
possessing zinc-binding groups of the sulfamide, sulfamate or sulfonamide type
in their molecules.
|
 |
|
|
|
|
 |